CTI BioPharma Corp (CTIC) Stock Adds 0.11% This Week; Should You Buy?

Wednesday, May 17, 2023 01:19 PM | InvestorsObserver Analysts

Mentioned in this article

CTI BioPharma Corp (CTIC) Stock Adds 0.11% This Week; Should You Buy?

CTI BioPharma Corp (CTIC) stock is up 103.18% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CTIC stock a score of 63 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 100. CTIC's rank also includes a long-term technical score of 88.

CTIC has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on CTIC!

See Full CTIC Report

What's Happening with CTIC Stock Today

CTI BioPharma Corp (CTIC) stock is up 0.28% while the S&P 500 is up 1.06% as of 1:17 PM on Wednesday, May 17. CTIC is up $0.03 from the previous closing price of $8.91 on volume of 3,360,473 shares. Over the past year the S&P 500 has gained 1.58% while CTIC is up 103.18%. CTIC lost -$0.81 per share in the over the last 12 months. Click Here to get the full Stock Report for CTI BioPharma Corp stock.